QSO Memo 20-21 CLIA: Laboratory guidance during COVID-19 public health emergency

March 26, 2020 – CMS is issuing this memorandum to laboratory surveyors to provide important guidance to surveyors and laboratories during the COVID-19 public health emergency, such as: CMS’ Exercise of enforcement discretion to ensure pathologists may review pathology slides remotely if certain defined conditions are met Ensuring that laboratories located in the United States…

Read more

Laboratory Alert: Discontinue use of the A549/MV1LU Mix for respiratory viral culture panels and review updated biosafety FAQs

Because of the risk of infection with SARS-CoV-2 among laboratory workers, CDC recommends that laboratories discontinue the use of the A549/MV1LU mix when they perform respiratory viral culture panels. Using these specific cell lines has been shown to result in a very low level of SARS-CoV replication. CDC recommends that laboratories perform respiratory viral culture…

Read more

FDA offers strategies for conservation of PPE

The U.S. Food and Drug Administration (FDA) has released a letter addressing conservation strategies for use by health care organizations and personnel for personal protective equipment (PPE), such as medical gloves; the strategies are categorized for a range of needs and supply levels and are intended to assist health care organizations as they determine procedures…

Read more